Camp4 Therapeutics (CAMP) Other Working Capital Changes (2023 - 2026)
Camp4 Therapeutics (CAMP) posted Other Working Capital Changes of -$1.2 million for Q1 2026, down 106.91% sequentially from $17.5 million in Q4 2025, and down 214.29% YoY from $1.1 million in Q1 2025.
Analysis
Camp4 Therapeutics (CAMP) Other Working Capital Changes (2023 - 2026) Analysis & Trends
Camp4 Therapeutics has reported Other Working Capital Changes for 3 years, with the latest figure at -$1.2 million in Q1 2026.
- Quarterly Other Working Capital Changes fell 214.29% year-over-year to -$1.2 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $16.3 million (changed N/A YoY) and the FY2025 annual result came in at $17.1 million, up 4345.45% from the prior year.
- Other Working Capital Changes fell to -$1.2 million in Q1 2026 per CAMP's latest filing, from $17.5 million in the prior quarter.
- Over five years, Other Working Capital Changes peaked at $1.2 million in Q1 2024 and troughed at -$974000.0 in Q1 2026.
- A 4-year average of $71200.0 and a median of $47000.0 in 2023 frame the typical range for Other Working Capital Changes.
- The sharpest annual moves came in 2025 and 2026: Other Working Capital Changes jumped 4445.45% in 2025, then slumped 214.29% in 2026.
- Over 3 years, Other Working Capital Changes stood at $385000.0 in 2024, then surged by 4445.45% to $17.5 million in 2025, then tumbled by 106.91% to -$1.2 million in 2026.
- According to Business Quant data, Other Working Capital Changes over the past three periods registered -$1.2 million, $17.5 million, and -$385000.0 for Q1 2026, Q4 2025, and Q1 2025 respectively.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 138.47 Bn | 130.62 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.18 Bn | 77.19 Bn | 3.93 Bn |
| 3 | Argenx Se | 63.38 Bn | 58.19 Bn | 1.37 Bn |
| 4 | Moderna | 58.09 Bn | 52.95 Bn | 52.00 Mn |
| 5 | Revolution Medicines | 44.33 Bn | 44.33 Bn | - |
| 6 | BeOne Medicines | 40.02 Bn | 34.92 Bn | 1.53 Bn |
| 7 | Alnylam Pharmaceuticals | 35.57 Bn | 32.27 Bn | 992.69 Mn |
| 8 | Royalty Pharma | 28.45 Bn | 27.61 Bn | - |
| 9 | Insmed | 27.48 Bn | 26.32 Bn | 358.27 Mn |
| 10 | Camp4 Therapeutics | 260.10 Mn | 260.10 Mn | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 641,000.00 |
| Jun 30, 2026 | 641,000.00 |
| Mar 31, 2026 | -974,000.00 |
| Mar 31, 2026 | -974,000.00 |
| Dec 31, 2025 | 779,000.00 |
| Dec 31, 2025 | 779,000.00 |
| Sep 30, 2025 | 1.56 Mn |
| Sep 30, 2025 | 1.56 Mn |
| Jun 30, 2025 | -1.46 Mn |
| Jun 30, 2025 | -1.46 Mn |
| Mar 31, 2025 | 7,000.00 |
| Mar 31, 2025 | 7,000.00 |
| Dec 31, 2024 | 368,000.00 |
| Dec 31, 2024 | 368,000.00 |
| Sep 30, 2024 | -203,000.00 |
| Sep 30, 2024 | -203,000.00 |
| Jun 30, 2024 | -652,000.00 |
| Jun 30, 2024 | -652,000.00 |
| Mar 31, 2024 | 1.20 Mn |
| Mar 31, 2024 | 1.20 Mn |